WELCOME to: 'Stu's Views and MS News' an informational archive provided by MS Views and News
· Key-Note: This blog provides education, information and resources to benefit those affected by Multiple Sclerosis.
· Opt-In at our website (MS Views and News) to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in more than (90) Countries.
· Our live MS educational seminars average 67 people per educational program. SINCE our first program in February 2010, we have hosted more than 130 educational programs.
· Visit our Multiple Sclerosis Learning channel on YouTube archived by topic here: www.youtube.com/msviewsandnews
Be Empowered with Beneficial MS Information - ---Visit MS Views and News.org
View all the resources found on the left side of this blog. Use our 'search by topic' tool, when wanting to find specificinformation.
Monday, October 8, 2012
Ampyra's worth, being questioned by an insurance carrier
Acorda sinks after insurance provider questions MS drug
Theflyonthewall.com via Yahoo! Finance Mon, 08 Oct 2012 08:41 AM PDT
Acorda Therapeutics (ACOR) is retreating after Group Health, which provides health insurance to over 600,000 people in the Northwest, questioned the necessity of the company's multiple sclerosis treatment, ...
THIS IS B.S. everybody and we need to Voice our concerns.
IF the FDA approved the medications, then they must have found worth in the drug(s)
Click here to read the blog posting about Aetna and Then, Call Aetna to voice your resentment to their decision. The phone numbers are found at that posting.